Cann Group Past Earnings Performance

Past criteria checks 0/6

Cann Group's earnings have been declining at an average annual rate of -23.8%, while the Pharmaceuticals industry saw earnings growing at 35.1% annually. Revenues have been growing at an average rate of 40.3% per year.

Key information

-23.8%

Earnings growth rate

1.9%

EPS growth rate

Pharmaceuticals Industry Growth31.2%
Revenue growth rate40.3%
Return on equity-368.1%
Net Margin-279.1%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Cann Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

CHIA:CAN Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 2418-51191
31 Mar 2420-40201
31 Dec 2321-29352
30 Sep 2321-32353
30 Jun 2321-34194
31 Mar 2318-35234
31 Dec 2214-37275
30 Sep 2213-32274
30 Jun 2211-26283
31 Mar 2210-25272
31 Dec 219-24262
30 Sep 219-25252
30 Jun 219-25232
31 Mar 217-22192
31 Dec 206-18152
30 Sep 204-17142
30 Jun 202-17141
31 Mar 202-16151
31 Dec 193-14161
30 Sep 193-13151
30 Jun 193-11131
31 Mar 192-10111
31 Dec 181-891
30 Sep 181-671
30 Jun 181-561
31 Mar 180-441
31 Dec 170-320
30 Sep 170-321
30 Jun 170-321
30 Jun 160-110
30 Jun 150-440

Quality Earnings: CAN is currently unprofitable.

Growing Profit Margin: CAN is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: CAN is unprofitable, and losses have increased over the past 5 years at a rate of 23.8% per year.

Accelerating Growth: Unable to compare CAN's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CAN is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (26.6%).


Return on Equity

High ROE: CAN has a negative Return on Equity (-368.09%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:26
End of Day Share Price 2024/12/23 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Cann Group Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Cameron BellCanaccord Genuity
Paul JenszPAC Partners Securities Pty. Ltd.